deoxycytidine has been researched along with Leukemia, Myeloid, Acute in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (35.14) | 18.7374 |
1990's | 3 (8.11) | 18.2507 |
2000's | 13 (35.14) | 29.6817 |
2010's | 7 (18.92) | 24.3611 |
2020's | 1 (2.70) | 2.80 |
Authors | Studies |
---|---|
Baginska, P; Czyz, J; Gackowski, D; Gawronski, M; Jachalska, A; Kruszewski, M; Labejszo, A; Olinski, R; Rozalski, R; Sadowska, A; Siomek-Gorecka, A; Skalska-Bugala, A; Starczak, M; Szpila, A; Szpotan, J; Szukalska, A; Szukalski, Ł; Wasilow, A; Zarakowska, E | 1 |
Baker, SD; Buelow, DR; Cotton, A; Dang, J; Drenberg, CD; Fu, Q; Gruber, TA; Guy, RK; Hu, S; Inaba, H; Jeon, JY; Li, M; Orwick, SJ; Pioso, M; Ribeiro, RC; Rubnitz, JE; Shelat, A | 1 |
Annereau, JP; Bailly, C; Bonnet, D; Brel, V; Créancier, L; Currie, E; Fournier, E; Gomes, B; Guilbaud, N; Guminski, Y; Kruczynski, A; Pillon, A; Vandenberghe, I | 1 |
Borders, EB; Cherry, MA; Herman, T; Holter, J; Selby, GB; Srour, SA | 1 |
Berda, Y; Ciccolini, J; Costello, R; Fanciullino, R; Fina, F; Lacarelle, B; Mercier, C; Ouafik, L; Serdjebi, C | 1 |
Lin, J; Ma, JC; Qian, J; Wang, YX; Wen, XM; Yang, DQ; Yang, J; Yang, L; Zhang, TJ; Zhou, JD | 1 |
Baker, SD; Blum, W; Drenberg, CD; Du, G; Gibson, AA; Gruber, TA; Hu, S; Li, L; Nies, AT; Pabla, N; Pounds, SB; Rhinehart, DP; Schwab, M; Shi, L; Sparreboom, A | 1 |
Adams, DJ; Decastro, CM; Gockerman, JP; Moore, JO; Peterson, BL; Petros, WP; Rao, AV; Rizzieri, DA; Sand, GJ; Spasojevic, I; Younis, IR | 1 |
Gibbons, S; Tansley, S | 1 |
Bellavia, T; Damodaran, S; Khushalani, NI; Sait, SN; Wang, ES; Wetzler, M | 1 |
Apostolidou, E; Cortes, J; Estey, E; Faderl, S; Garcia-Manero, G; Giles, FJ; Kantarjian, H; Thomas, D; Tsimberidou, A | 1 |
Adams, DJ; Chao, NJ; DeCastro, CM; Foster, T; Gasparetto, C; Gockerman, JP; Ibom, VK; Long, GD; Moore, JO; Payne, N; Rizzieri, DA; Rosner, GL; Thompson, M; Vredenburgh, JJ | 1 |
Cortes, J; Giles, F; Kantarjian, H; Ravandi, F | 1 |
Hao, CL; Lin, D; Wang, JX; Wang, LH; Wang, M; Xing, HY | 1 |
Angiolillo, AL; Chen, Z; Krailo, M; Reaman, G; Whitlock, J | 1 |
Hudson, MM | 1 |
Boos, J; Henze, G; von Stackelberg, A; Wagner-Bohn, A | 1 |
Adema, AD; Albertoni, F; Floor, K; Hubeek, I; Kaspers, GJ; Peters, GJ; Zuurbier, L | 1 |
Carlson, J; Keoffler, HP; Yen, J | 1 |
Evans, WE; Sinkule, JA | 1 |
Breatnach, F; Ganeshaguru, K; Hoffbrand, AV; Lee, N; Piga, A; Prentice, HG | 1 |
Grahame-Smith, DG; Harris, AL | 1 |
Baker, M; Bhalla, K; Grant, S | 1 |
Azuma, A; Huang, P; Li, YX; Plunkett, W; Sampath, D; Shi, Z | 1 |
Azuma, A; Huang, P; Matsuda, A; Plunkett, W | 1 |
Ayres, M; Du, M; Estey, EH; Gandhi, V; Plunkett, W | 1 |
Chabner, BA; Coleman, CN; Drake, JC; Stoller, RG | 1 |
Buchman, VM; Lichinitser, MR; Mkheidze, DM; Svet-Moldavsky, GJ | 1 |
Chabner, BA; Coleman, CN; Johns, DG | 1 |
Cheng, YC; Domin, B; Lee, LS | 1 |
Bukhman, VM; Lichinitser, MR; Mkheidze, DM; Svet-Moldavskiĭ, GIa | 1 |
Hirt, A; Wagner, HP | 1 |
Cuddy, DP; de Valeriola, DL; Egorin, MJ; Forrest, A; Ross, DD | 1 |
Grant, S; Howe, C; Kuczynski, T | 1 |
Bhalla, K; Gleyzer, M; Grant, S | 1 |
Ganeshaguru, K; Hoffbrand, AV; Tattersall, MH | 1 |
Ho, DH | 1 |
1 review(s) available for deoxycytidine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
New agents in acute myeloid leukemia and other myeloid disorders.
Topics: Antineoplastic Agents; Cyclosporine; Cytosine; Deoxycytidine; Dioxolanes; Female; Gemcitabine; Humans; Immunosuppressive Agents; Immunotherapy; Leukemia, Myeloid, Acute; Male; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2004 |
7 trial(s) available for deoxycytidine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Half-Life; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Salvage Therapy; Tissue Distribution; Vidarabine | 2008 |
Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Deoxycytidine; Gemcitabine; Humans; Infusions, Parenteral; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Mouth Mucosa; Pilot Projects; Remission Induction; Salvage Therapy; Sepsis; Stomatitis; Treatment Outcome | 2003 |
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Deoxycytidine; Esophagitis; Gemcitabine; Humans; Infusions, Intravenous; Injections, Intravenous; Leukemia, Myeloid, Acute; Metabolic Clearance Rate; Middle Aged; Recurrence; Stomatitis; Vidarabine | 2003 |
Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): a Children's Oncology Group Report.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Child; Child, Preschool; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Infant; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Treatment Failure | 2006 |
Phase II study of gemcitabine in children with relapsed leukemia.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Deoxycytidine; Female; Gemcitabine; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2006 |
Phase I study of a continuous infusion of high-dose ara-C in conjunction with a fixed dose of 2'-deoxycytidine (IND 28108) in patients with refractory leukemia: an interim report.
Topics: Adult; Aged; Blast Crisis; Cytarabine; Deoxycytidine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Remission Induction; Thrombocytopenia | 1993 |
Prolonged infusion of gemcitabine: clinical and pharmacodynamic studies during a phase I trial in relapsed acute myelogenous leukemia.
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; DNA; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male | 2002 |
29 other study(ies) available for deoxycytidine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes.
Topics: Deoxycytidine; Deoxyuridine; DNA; DNA Demethylation; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Prognosis | 2022 |
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Cell Line, Tumor; Child; Child, Preschool; Cytarabine; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; High-Throughput Screening Assays; Humans; Infant; Janus Kinase Inhibitors; Leukemia, Experimental; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Taxoids; Whole-Body Irradiation; Xenograft Model Antitumor Assays; Young Adult | 2019 |
F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Proliferation; Cytarabine; Deoxycytidine; Doxorubicin; Fetal Blood; Flow Cytometry; Gemcitabine; Humans; Hydroxamic Acids; Immunoenzyme Techniques; Interleukin Receptor Common gamma Subunit; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Podophyllotoxin; Pyrazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays | 2013 |
Role of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retreatment; Thiotepa; Topotecan; Treatment Outcome; Vinblastine; Vinorelbine | 2015 |
Lethal toxicity after administration of azacytidine: implication of the cytidine deaminase-deficiency syndrome.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cytarabine; Cytidine Deaminase; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Inactivation, Metabolic; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Polymorphism, Single Nucleotide | 2015 |
DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Child; Child, Preschool; Deoxycytidine; DNA Methylation; Female; Homeodomain Proteins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Prognosis; Remission Induction; RNA, Messenger; Transcription Factors; Young Adult | 2016 |
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.
Topics: Animals; Antimetabolites, Antineoplastic; Child; CHO Cells; Cohort Studies; Cricetulus; Cytarabine; Deoxycytidine; Dipyridamole; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Profiling; HEK293 Cells; HeLa Cells; Humans; Leukemia, Myeloid, Acute; Organic Cation Transport Proteins; Symporters | 2017 |
Capecitabine-induced acute myeloid leukaemia.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Male; Prodrugs; Sigmoid Neoplasms | 2009 |
Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.
Topics: Abnormal Karyotype; Adenocarcinoma; Antineoplastic Agents; Capecitabine; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Deoxycytidine; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Organoplatinum Compounds; Oxaliplatin; Radiotherapy; Translocation, Genetic | 2012 |
[Combination of phenylbutyrate and 5-Aza-2'deoxycytidine inhibits human Kasumi-1 xenograft tumor growth in nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Disease Models, Animal; Flow Cytometry; Humans; In Situ Nick-End Labeling; Leukemia, Myeloid, Acute; Mice; Mice, Nude; Phenylbutyrates; Tumor Burden; Xenograft Model Antitumor Assays | 2004 |
Achieving cure for early stage pediatric Hodgkin disease with minimal morbidity: are we there yet?
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Child; Child, Preschool; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Infant; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Treatment Failure | 2006 |
Cellular resistance against troxacitabine in human cell lines and pediatric patient acute myeloid leukemia blast cells.
Topics: Antineoplastic Agents; Catalysis; Cell Line, Tumor; Cladribine; Cytosine; Deoxycytidine; Dioxolanes; Drug Resistance, Neoplasm; Gemcitabine; HeLa Cells; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Models, Chemical; Nucleosides | 2006 |
The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
Topics: Bromodeoxyuridine; Cell Differentiation; Cell Line; Deoxycytidine; DNA; Granulocytes; Humans; Idoxuridine; Kinetics; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Macrophages; Thymidine; Thymidine Kinase | 1983 |
High-performance liquid chromatographic assay for cytosine arabinoside, uracil arabinoside and some related nucleosides.
Topics: Arabinofuranosyluracil; Child; Chromatography, High Pressure Liquid; Cytarabine; Cytidine; Deoxycytidine; Humans; Infusions, Parenteral; Kinetics; Leukemia, Myeloid, Acute; Uridine | 1983 |
DNA synthesis in thymic-acute lymphoblastic leukaemia.
Topics: Bone Marrow; Deoxycytidine; Deoxyribonucleosides; DNA; DNA, Neoplasm; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Myasthenia Gravis; Thymidine; Thymus Gland | 1981 |
Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Deoxycytidine; DNA, Neoplasm; Humans; Kinetics; Leukemia, Myeloid, Acute; Phosphorylation; Tetrahydrouridine | 1981 |
S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine.
Topics: Alkaloids; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Humans; Leukemia, Myeloid, Acute; S Phase; Staurosporine; Tumor Cells, Cultured | 2001 |
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest.
Topics: Antineoplastic Agents; CDC2 Protein Kinase; Chromosome Breakage; Cyclin B; Cyclin B1; Cytarabine; Deoxycytidine; DNA, Neoplasm; G2 Phase; Gemcitabine; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Phosphorylation; RNA; Tumor Cells, Cultured | 2001 |
Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes.
Topics: Azacitidine; Blood Proteins; Cell Separation; Cell-Free System; Cytarabine; Cytidine Deaminase; Deoxycytidine; Granulocytes; Humans; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Molecular Weight; Phosphates; Phosphotransferases; Tissue Extracts; Uridine Kinase | 1975 |
Deoxycytidine and lethal doses of cytarabine in advanced murine leukaemia.
Topics: Administration, Oral; Animals; Cytarabine; Deoxycytidine; Drug Antagonism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mice | 1977 |
Studies on mechanisms of resistance to cytosine arabinoside: problems in the determination of related enzyme activities in leukemic cells.
Topics: Bone Marrow; Bone Marrow Cells; Cytarabine; Cytidine Deaminase; Deoxycytidine; Drug Resistance; Erythrocytes; Granulocytes; Humans; Kinetics; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Nucleoside Deaminases; Phosphotransferases; Tetrahydrouridine | 1975 |
Human deoxycytidine kinase. Purification and characterization of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia patients.
Topics: Chromatography, Affinity; Cytoplasm; Deoxycytidine; Enzyme Activation; Humans; Kinetics; Leukemia, Myeloid, Acute; Magnesium; Mitochondria; Molecular Weight; Phosphotransferases; Ribonucleosides; Structure-Activity Relationship; Thermodynamics | 1977 |
[Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside].
Topics: Administration, Oral; Animals; Cytarabine; Deoxycytidine; Drug Evaluation; Drug Therapy, Combination; Injections, Intraperitoneal; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice | 1978 |
Nuclear incorporation of radioactive DNA precursors and progression of cells through S. Combined radioautographic and cytophotometric studies on normal and leukaemic bone marrow and thoracic duct lymph cells of man.
Topics: Aged; Bone Marrow; Bone Marrow Cells; Cell Nucleus; Child; Child, Preschool; Deoxycytidine; DNA; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lymphocytes; Male; Mitosis; Scleroderma, Systemic; Thymidine; Tritium | 1975 |
Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs.
Topics: Adult; Aged; Cytarabine; Daunorubicin; Deoxycytidine; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tumor Cells, Cultured | 1991 |
Selective eradication of leukemic (L-CFU) versus normal (CFU-GM) myeloid progenitors in suspension culture utilizing a prolonged exposure to 1-B-D arabinofuranosylcytosine (Ara-C) and deoxycytidine (dCyd).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Cells, Cultured; Cytarabine; Deoxycytidine; Granulocytes; Humans; Leukemia, Myeloid, Acute; Macrophages; Neoplastic Stem Cells; Stem Cells; Tumor Cells, Cultured | 1990 |
Interaction of deoxycytidine and deoxycytidine analogs in normal and leukemic human myeloid progenitor cells.
Topics: Azacitidine; Cell Division; Cell Line; Colony-Forming Units Assay; Cytarabine; Decitabine; Deoxycytidine; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute | 1986 |
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside.
Topics: Adult; Aminohydrolases; Bone Marrow; Bone Marrow Cells; Cytarabine; Deoxycytidine; Deoxyribonucleosides; Drug Resistance; Humans; Kinetics; Leukemia, Myeloid, Acute; Phosphotransferases; Tritium | 1974 |
Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse.
Topics: Aminohydrolases; Animals; Bone Marrow; Bone Marrow Cells; Cytarabine; Deoxycytidine; Humans; Kidney; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Liver; Mice; Phosphotransferases; Spleen; Uridine | 1973 |